share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director BLAYLOCK RONALD E

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director BLAYLOCK RONALD E

輝瑞 | 4：持股變動聲明-董事 BLAYLOCK RONALD E
美股sec公告 ·  04/27 01:24
牛牛AI助理已提取核心訊息
Ronald E. Blaylock, a reporting person for Pfizer Inc. [PFE], has engaged in a transaction involving the company's stock on April 25, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for Mr. Blaylock is 66 Hudson Boulevard East, New York, NY, 10001-2192. The relationship of Mr. Blaylock to Pfizer Inc. was not specified in the provided information.
Ronald E. Blaylock, a reporting person for Pfizer Inc. [PFE], has engaged in a transaction involving the company's stock on April 25, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for Mr. Blaylock is 66 Hudson Boulevard East, New York, NY, 10001-2192. The relationship of Mr. Blaylock to Pfizer Inc. was not specified in the provided information.
輝瑞公司 [PFE] 的申報人羅納德·布萊洛克於2024年4月25日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。爲布萊洛克先生提供的地址是紐約州紐約哈德遜大道東66號，郵編10001-2192。提供的資料中沒有具體說明布萊洛克先生與輝瑞公司的關係。
輝瑞公司 [PFE] 的申報人羅納德·布萊洛克於2024年4月25日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。爲布萊洛克先生提供的地址是紐約州紐約哈德遜大道東66號，郵編10001-2192。提供的資料中沒有具體說明布萊洛克先生與輝瑞公司的關係。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。